RX-1 Rhythm Express Remote Cardiac Monitoring System vs Zio XT ECG Monitoring System

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

These two tools are direct competitors, both offering FDA-cleared, AI-powered wearable ECG systems for remote cardiac monitoring. Tool A provides 2-channel ECG monitoring with near real-time data transmission, making it suitable for scenarios requiring immediate data access. Tool B focuses on extended wear with up to 14 days of continuous single-lead monitoring, prioritizing patient convenience for longer-term rhythm assessment.

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose the RX-1 Rhythm Express if your practice requires versatile cardiac monitoring with multiple modes (MCT, Event, and Holter) and the ability to capture 2-channel ECG data. This system is ideal for scenarios where near real-time data transmission and superior noise suppression are critical for timely diagnosis and intervention, especially for patients with potentially unstable arrhythmias.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Choose Zio XT ECG Monitoring System if…

Choose the Zio XT ECG Monitoring System if you prioritize extended, comfortable, and highly compliant cardiac monitoring for up to 14 days. This single-lead, leadless biosensor is particularly well-suited for detecting infrequent arrhythmias in patients who benefit from an unobtrusive device that supports normal daily activities and ensures high diagnostic yield.

View Zio XT ECG Monitoring System →

For physicians evaluating remote cardiac monitoring solutions, the RX-1 Rhythm Express and Zio XT systems offer distinct advantages. The RX-1 Rhythm Express, with its patch-style wearable and proprietary MDSP™ technology, excels in providing continuous 2-channel ECG monitoring across MCT, Event, and Holter modes. This makes it particularly strong for practices requiring flexible monitoring durations and advanced noise suppression for clearer signal quality, especially in scenarios where detailed, multi-lead data is beneficial for arrhythmia detection. Its near real-time data transmission to a cloud platform also supports more immediate physician review.

The Zio XT, on the other hand, utilizes a single-lead ECG biosensor for up to 14 days of continuous monitoring, leveraging FDA-cleared AI and expert review for analysis. Its key practical difference lies in its simpler, lead-free design, which often translates to higher patient compliance and comfort for extended wear. Physicians prioritizing ease of use for patients and a streamlined, long-duration monitoring approach with robust AI-driven analysis may find Zio XT more suitable. Ultimately, practices needing multi-mode flexibility and advanced signal processing might lean towards RX-1, while those valuing patient comfort, extended wear, and a simplified, single-lead approach may prefer Zio XT.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System Zio XT ECG Monitoring System
Pricing Available via subscription, fee-for-service, or split-bill models. Contact for pricing
Deployment Wearable device for patients, cloud-based platform for data management and review. Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool B (Zio XT) offers a significant advantage with up to 14 days of continuous wear without needing to manage wires or batteries, promoting higher patient compliance. In contrast, Tool A (RX-1 Rhythm Express) requires recharging every 5 days and uses leads, which may be less convenient for extended patient use.

Clinical Value

Zio XT ECG Monitoring System

Tool B (Zio XT) demonstrates superior clinical value through extensive real-world evidence, with studies showing the highest diagnostic yield, fastest time to diagnosis, and lowest retesting rates compared to other ambulatory cardiac monitors. While Tool A offers 2-channel ECG and near real-time data for MCT, Tool B's proven long-term monitoring effectiveness and high analytic/clinical validity are stronger indicators of overall clinical utility.

Pricing & Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A (RX-1 Rhythm Express) provides transparent and flexible pricing models, including subscription, fee-for-service, and split-bill options, directly in its published specifications. This allows clinics to clearly understand and choose the model that best suits their financial needs. Tool B's general pricing requires direct contact, although it does provide some specific regional cost indications.

Enterprise Readiness

RX-1 Rhythm Express Remote Cardiac Monitoring System

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating a strong foundation for enterprise use. Tool A (RX-1 Rhythm Express) further enhances its enterprise readiness by highlighting ISO 13485 certification for its Quality Management System and NSA-level encryption for data transmission.

Innovation

Zio XT ECG Monitoring System

While Tool A (RX-1 Rhythm Express) features innovative MDSPu2122 technology for noise suppression and 2-channel ECG, Tool B (Zio XT) stands out with its proprietary deep-learned AI algorithm combined with a 14-day, wire-free, single-lead biosensor. This design significantly improves patient experience and has demonstrated high compliance and diagnostic yield in large studies, representing a more impactful innovation in patient-centric monitoring.

Support & Docs

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A (RX-1 Rhythm Express) explicitly states 24/7/365 support availability and expedited replacement shipping, which are critical for maintaining continuous patient monitoring and operational efficiency. While Tool B also offers patient and clinician documentation and customer care, Tool A's detailed commitment to continuous, immediate support gives it an edge in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System Zio XT ECG Monitoring System
Name RX-1 Rhythm Express Remote Cardiac Monitoring System Zio XT ECG Monitoring System
Company VivaQuant iRhythm Technologies
Monitoring Duration Up to 5 days on a single charge (typically 1 day to 4 weeks) Up to 14 days
ECG Channels/Lead 2-channel ECG monitoring Single-lead ECG biosensor
Monitoring Modes Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH) modes Continuous ambulatory cardiac monitoring
Key Signal Processing/AI Proprietary Multi-Domain Signal Processing (MDSPu2122) technology for noise suppression, AI-enabled advanced signal processing for arrhythmia detection Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis
Water Resistance Water-resistant (IP64) Water-resistant design for normal daily activities, including showering

Videos

Demos, reviews, and walkthroughs featuring RX-1 Rhythm Express Remote Cardiac Monitoring System and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The RX-1 Rhythm Express offers continuous 2-channel ECG monitoring with up to 5 days of battery life, supporting Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH) modes. In contrast, the Zio XT provides continuous single-lead ECG monitoring for up to 14 days.
The RX-1 Rhythm Express features built-in cellular connectivity for near real-time data transmission to a cloud platform for physician review. The Zio XT utilizes a cloud-based software platform (ZEUS) for data storage, analysis, and reporting, with data analyzed by a proprietary algorithm and reviewed by a Certified Cardiographic Technician before a report is generated for the physician.
The RX-1 Rhythm Express utilizes proprietary Multi-Domain Signal Processing (MDSPu2122) technology for superior noise suppression and AI-enabled advanced signal processing for accurate arrhythmia detection. The Zio XT employs a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis.
The RX-1 Rhythm Express is a compact, patch-style wearable that is water-resistant (IP64) and designed for continuous monitoring, even during showers. The Zio XT is a wearable single-lead ECG biosensor with no external leads or wires for enhanced patient comfort, is water-resistant for normal daily activities including showering, and boasts high patient compliance.
The RX-1 Rhythm Express is primarily listed for Cardiology. The Zio XT is listed for Cardiology, Emergency Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.